The diabetic experience: help on the way?

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2013/04/IV-AA370_DIABET_G_201304051645212.jpg” thumb_width=”175″ /]Last week’s article on the limitations of QSing outlined the precursor ‘fly in ointment’: how diabetics have been living long-term with monitoring and self-management. Type 1 diabetes is the ‘Battle of Stalingrad’ for life. The ideal is to create a device that replaces the non-functioning pancreas, which releases insulin in the amount and time as needed to closely balance blood glucose and avoid devastating seizures and blackouts. Technology available for the past few years in Europe is just now (to this Editor’s amazement) in FDA approval in the US (Medtronic’s insulin pump.) Closer to the ideal is an insulin pump that connects to a continuous glucose monitor, which is being developed by Johnson & Johnson’s Animas division. The market, according to the JDRF, is 3 million people in the US. For Diabetics, a Longtime Goal Is Within Reach (Wall Street Journal)